Carbohydrate restriction in patients with advanced cancer

A protocol to assess safety and feasibility with an accompanying hypothesis

Eugene J. Fine, C. J. Segal-Isaacson, Richard Feinman, Joseph A. Sparano

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Dietary carbohydrate restriction provokes systemic metabolic and cell signaling effects including down-regulation of insulin, insulin-like growth factors, fatty acid synthase, and other enzymatic and signaling targets. These effects as well as increased availability of fatty acids and ketone bodies may plausibly inhibit aggressive glycolytic cancers. We have designed a 28-day clinical trial diet of very low carbohydrate intake under nutritionist guidance to test the safety and feasibility in patients with advanced glucose-dependent solid cancers, determined by a positive baseline positron emission tomography (PET) scan using 18-fluorodeoxyglucose to demonstrate glucose avidity. Changes in a follow-up PET scan at study's end permit a surrogate measure of efficacy.

Original languageEnglish (US)
Pages (from-to)22-26
Number of pages5
JournalCommunity Oncology
Volume5
Issue number1
StatePublished - Jan 2008

Fingerprint

Positron-Emission Tomography
Carbohydrates
Carbohydrate-Restricted Diet
Dietary Carbohydrates
Safety
Glucose
Fatty Acid Synthases
Ketone Bodies
Nutritionists
Somatomedins
Neoplasms
Fatty Acids
Down-Regulation
Clinical Trials
Insulin

ASJC Scopus subject areas

  • Oncology

Cite this

Carbohydrate restriction in patients with advanced cancer : A protocol to assess safety and feasibility with an accompanying hypothesis. / Fine, Eugene J.; Segal-Isaacson, C. J.; Feinman, Richard; Sparano, Joseph A.

In: Community Oncology, Vol. 5, No. 1, 01.2008, p. 22-26.

Research output: Contribution to journalArticle

@article{08dc2f9275624bce879fbf2a1219e288,
title = "Carbohydrate restriction in patients with advanced cancer: A protocol to assess safety and feasibility with an accompanying hypothesis",
abstract = "Dietary carbohydrate restriction provokes systemic metabolic and cell signaling effects including down-regulation of insulin, insulin-like growth factors, fatty acid synthase, and other enzymatic and signaling targets. These effects as well as increased availability of fatty acids and ketone bodies may plausibly inhibit aggressive glycolytic cancers. We have designed a 28-day clinical trial diet of very low carbohydrate intake under nutritionist guidance to test the safety and feasibility in patients with advanced glucose-dependent solid cancers, determined by a positive baseline positron emission tomography (PET) scan using 18-fluorodeoxyglucose to demonstrate glucose avidity. Changes in a follow-up PET scan at study's end permit a surrogate measure of efficacy.",
author = "Fine, {Eugene J.} and Segal-Isaacson, {C. J.} and Richard Feinman and Sparano, {Joseph A.}",
year = "2008",
month = "1",
language = "English (US)",
volume = "5",
pages = "22--26",
journal = "Community Oncology",
issn = "1548-5315",
publisher = "BioLink Communications",
number = "1",

}

TY - JOUR

T1 - Carbohydrate restriction in patients with advanced cancer

T2 - A protocol to assess safety and feasibility with an accompanying hypothesis

AU - Fine, Eugene J.

AU - Segal-Isaacson, C. J.

AU - Feinman, Richard

AU - Sparano, Joseph A.

PY - 2008/1

Y1 - 2008/1

N2 - Dietary carbohydrate restriction provokes systemic metabolic and cell signaling effects including down-regulation of insulin, insulin-like growth factors, fatty acid synthase, and other enzymatic and signaling targets. These effects as well as increased availability of fatty acids and ketone bodies may plausibly inhibit aggressive glycolytic cancers. We have designed a 28-day clinical trial diet of very low carbohydrate intake under nutritionist guidance to test the safety and feasibility in patients with advanced glucose-dependent solid cancers, determined by a positive baseline positron emission tomography (PET) scan using 18-fluorodeoxyglucose to demonstrate glucose avidity. Changes in a follow-up PET scan at study's end permit a surrogate measure of efficacy.

AB - Dietary carbohydrate restriction provokes systemic metabolic and cell signaling effects including down-regulation of insulin, insulin-like growth factors, fatty acid synthase, and other enzymatic and signaling targets. These effects as well as increased availability of fatty acids and ketone bodies may plausibly inhibit aggressive glycolytic cancers. We have designed a 28-day clinical trial diet of very low carbohydrate intake under nutritionist guidance to test the safety and feasibility in patients with advanced glucose-dependent solid cancers, determined by a positive baseline positron emission tomography (PET) scan using 18-fluorodeoxyglucose to demonstrate glucose avidity. Changes in a follow-up PET scan at study's end permit a surrogate measure of efficacy.

UR - http://www.scopus.com/inward/record.url?scp=38949193472&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38949193472&partnerID=8YFLogxK

M3 - Article

VL - 5

SP - 22

EP - 26

JO - Community Oncology

JF - Community Oncology

SN - 1548-5315

IS - 1

ER -